Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Prepaid Assets (2016 - 2026)

Ironwood Pharmaceuticals' Prepaid Assets history spans 16 years, with the latest figure at $12.0 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets changed 0.45% to $12.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $12.0 million, a 0.45% change, with the full-year FY2025 number at $12.0 million, changed 0.45% from a year prior.
  • Prepaid Assets hit $12.0 million in Q4 2025 for Ironwood Pharmaceuticals, down from $13.1 million in the prior quarter.
  • Over the last five years, Prepaid Assets for IRWD hit a ceiling of $22.5 million in Q2 2023 and a floor of $7.0 million in Q3 2022.
  • Historically, Prepaid Assets has averaged $12.1 million across 5 years, with a median of $12.0 million in 2023.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 158.34% in 2023 and later crashed 35.34% in 2024.
  • Tracing IRWD's Prepaid Assets over 5 years: stood at $8.7 million in 2021, then fell by 11.21% to $7.7 million in 2022, then surged by 55.7% to $12.0 million in 2023, then fell by 0.74% to $11.9 million in 2024, then increased by 0.45% to $12.0 million in 2025.
  • Business Quant data shows Prepaid Assets for IRWD at $12.0 million in Q4 2025, $13.1 million in Q3 2025, and $12.7 million in Q2 2025.